Is Krishna Institute of Medical Sciences Ltd debt-free?

Yes, Krishna Institute of Medical Sciences Ltd is debt-free with a debt-to-equity ratio of 0.33.

Home

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd Financials

Krishna Institute of Medical Sciences Ltd Financial Statement

Krishna Institute of Medical Sciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Jun 2025	Mar 2025	Dec 2024
Revenue	385.60	380.90	368.10
Operating Expense	275.90	237.20	244.60
Net Profit	58.80	93.50	76.50
Net Profit Margin	15.25	24.55	20.78
Earning Per Share	1.47	2.34	1.91
EBIDTA	106.20	137.10	121.70
Effective Tax Rate	15.86	14.20	19.11

Particulars	Jun 2025
Revenue	385.60
Operating Expense	275.90
Net Profit	58.80
Net Profit Margin	15.25
Earning Per Share	1.47
EBIDTA	106.20
Effective Tax Rate	15.86

Krishna Institute of Medical Sciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	1,384.10	1,222.10	1,132.02
Operating Expenses Annual	967.60	860.40	771.74
Operating Profit Annual	484	379.90	383.78
Interest Annual	23.20	3.60	1.15
Depreciation	52.20	53.30	41.94
Net Profit Annual	302.90	235.30	252.49
Tax Annual	100.20	82.90	84.84

Particulars	Mar 2025
Total Revenue Annual	1,384.10
Operating Expenses Annual	967.60
Operating Profit Annual	484
Interest Annual	23.20
Depreciation	52.20
Net Profit Annual	302.90
Tax Annual	100.20

Krishna Institute of Medical Sciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	20.50	38.10	19.86
Cash Flow from Operations	293.60	262.40	271.05
Cash Flow from Investing	-626.60	-568.60	-237.67
Cash Flow from Financing	338.60	288.60	-15.14
Cash Flow at the End	26.10	20.50	38.10

Particulars	Mar 2025
Cash Flow at the Beginning	20.50
Cash Flow from Operations	293.60
Cash Flow from Investing	-626.60
Cash Flow from Financing	338.60
Cash Flow at the End	26.10

Krishna Institute of Medical Sciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	35.29	31.40	34.22
PBIT Margin (%)	31.12	26.64	30.22
PBT Margin (%)	29.99	23.04	23.92
Net PROFIT Margin (%)	21.88	19.25	22.30
Return On Networth / Equity (%)	15.02	13.46	16.79
Return On Networth /Employed (%)	16.75	16.77	22.23
Return On Assets (%)	11.82	12.13	16.51
Total Debt / Equity (X)	0.26	0.09	0.01
Asset Turnover Ratio (%)	0.54	0.63	0.74

Particulars	Mar 2025
PBDIT Margin (%)	35.29
PBIT Margin (%)	31.12
PBT Margin (%)	29.99
Net PROFIT Margin (%)	21.88
Return On Networth / Equity (%)	15.02
Return On Networth /Employed (%)	16.75
Return On Assets (%)	11.82
Total Debt / Equity (X)	0.26
Asset Turnover Ratio (%)	0.54

Krishna Institute of Medical Sciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	773.30	673.90	612.28
Total Current Assets Annual	299.40	301.20	237.04
Non Current Assets Annual	2,889.70	2,095.40	1,575.02
Total Shareholders Funds Annual	2,168	1,866.40	1,630.86
Total Assets Annual	3,189.10	2,396.60	1,812.07

Particulars	Mar 2025
Fixed Assets Annual	773.30
Total Current Assets Annual	299.40
Non Current Assets Annual	2,889.70
Total Shareholders Funds Annual	2,168
Total Assets Annual	3,189.10

Krishna Institute of Medical Sciences Ltd Earning Calls

EPS (INR)

Expected

1.97

Reported

1.96

Surprise

-0.51%

Mar 2025

EPS beaten by -0.51%

Dec 2024

EPS beaten by -0.39%

Sep 2024

EPS beaten by 0.00%

Dividend Pages

PE Ratio

FAQS on Krishna Institute of Medical Sciences Ltd Financials

As of Aug 12, 2025, Krishna Institute of Medical Sciences Ltd has a market capitalization of 25,580.88 Cr. Value Research classifies it as a Large-Cap company.

Yes, Krishna Institute of Medical Sciences Ltd is with a debt-to-equity ratio of 0.33.

In FY 2024 , Krishna Institute of Medical Sciences Ltd recorded a total revenue of approximately 1,384.10 Cr marking a significant milestone in the company's financial performance.

Krishna Institute of Medical Sciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.1% annually, respectively..

Krishna Institute of Medical Sciences Ltd's current PE ratio is 84.45.

Krishna Institute of Medical Sciences Ltd's ROCE averaged 16.6% from the FY ending March 2023 to 2025, with a median of 14.7%. It peaked at 20.6% in March 2023, reflecting strong capital efficiency over the period..

Krishna Institute of Medical Sciences Ltd's latest EBIT is Rs. 426.30 Cr, surpassing the average EBIT of Rs. 362.19 Cr over the 5 years..